Correlation Between Agenus and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Agenus and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agenus and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agenus Inc and Nuvectis Pharma, you can compare the effects of market volatilities on Agenus and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agenus with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agenus and Nuvectis Pharma.
Diversification Opportunities for Agenus and Nuvectis Pharma
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Agenus and Nuvectis is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Agenus Inc and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Agenus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agenus Inc are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Agenus i.e., Agenus and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Agenus and Nuvectis Pharma
Given the investment horizon of 90 days Agenus is expected to generate 6.59 times less return on investment than Nuvectis Pharma. In addition to that, Agenus is 1.16 times more volatile than Nuvectis Pharma. It trades about 0.02 of its total potential returns per unit of risk. Nuvectis Pharma is currently generating about 0.15 per unit of volatility. If you would invest 515.00 in Nuvectis Pharma on November 26, 2024 and sell it today you would earn a total of 229.00 from holding Nuvectis Pharma or generate 44.47% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Agenus Inc vs. Nuvectis Pharma
Performance |
Timeline |
Agenus Inc |
Nuvectis Pharma |
Agenus and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Agenus and Nuvectis Pharma
The main advantage of trading using opposite Agenus and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agenus position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.Agenus vs. Marker Therapeutics | ||
Agenus vs. Edgewise Therapeutics | ||
Agenus vs. Adaptimmune Therapeutics Plc | ||
Agenus vs. Mereo BioPharma Group |
Nuvectis Pharma vs. Replimune Group | ||
Nuvectis Pharma vs. Lyra Therapeutics | ||
Nuvectis Pharma vs. Kronos Bio | ||
Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |